• 1. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260

Research Briefing on 4-(4-(hydroxymethyl)thiazol-2-yl)phenol (CAS: 885279-83-4) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound 4-(4-(hydroxymethyl)thiazol-2-yl)phenol (CAS: 885279-83-4) has recently garnered significant attention in the fields of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, including its synthesis, biological activity, and potential applications in drug development. The information presented herein is based on a thorough review of recent peer-reviewed publications, patent filings, and industry reports.

Recent studies have highlighted the role of 4-(4-(hydroxymethyl)thiazol-2-yl)phenol as a versatile scaffold in medicinal chemistry. Its thiazole and phenol moieties make it an attractive candidate for the development of novel bioactive molecules. Researchers have explored its potential as a building block for the synthesis of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds. The compound's ability to interact with various biological targets has been demonstrated through in vitro and in silico studies, suggesting its broad applicability in drug discovery.

One of the key advancements in the study of 4-(4-(hydroxymethyl)thiazol-2-yl)phenol is its application in the development of small-molecule inhibitors targeting specific enzymes involved in disease pathways. For instance, recent work has shown that derivatives of this compound exhibit potent inhibitory activity against certain kinases implicated in cancer progression. These findings have spurred further research into optimizing the compound's pharmacokinetic properties to enhance its therapeutic potential. Additionally, the compound's structural features have been leveraged to design probes for studying biological processes at the molecular level.

The synthesis and characterization of 4-(4-(hydroxymethyl)thiazol-2-yl)phenol have also been the focus of recent investigations. Advances in synthetic methodologies have enabled the efficient production of this compound and its derivatives, facilitating further exploration of its biological activities. Spectroscopic techniques, including NMR and mass spectrometry, have been employed to confirm the structure and purity of synthesized compounds, ensuring the reliability of subsequent biological assays. These efforts have laid the groundwork for the development of new chemical entities based on this scaffold.

In conclusion, 4-(4-(hydroxymethyl)thiazol-2-yl)phenol (CAS: 885279-83-4) represents a promising candidate for further research in chemical biology and pharmaceutical development. Its unique structural features, combined with its demonstrated biological activities, make it a valuable tool for drug discovery and mechanistic studies. Future research should focus on optimizing its derivatives for improved efficacy and safety, as well as exploring its potential in other therapeutic areas. This briefing underscores the importance of continued investment in the study of this compound to unlock its full potential in addressing unmet medical needs.

• 23780-13-4((2-phenylthiazol-4-yl)methanol)
• 885279-75-4(2-(4-methoxyphenyl)-1,3-thiazol-4-ylmethanol)
• 154037-50-0(4-Thiazolemethanol,2-(2-hydroxyphenyl)-)
• 885278-84-2((2-(3,5-dimethylphenyl)thiazol-4-yl)methanol)
• 885279-89-0(4-Thiazolemethanol,2-[4-(phenylmethoxy)phenyl]-)
• 36093-97-7((2-(p-Tolyl)thiazol-4-yl)methanol)
• 36093-99-9(2-(4-chlorophenyl)-1,3-thiazol-4-ylmethanol)
• 187793-07-3(4-Thiazolemethanol,2-(2-methoxyphenyl)-)
• 138330-01-5(4-(4-methyl-1,3-thiazol-2-yl)phenol)
• 145293-21-6(2-(4-Amino-phenyl)-thiazol-4-yl-methanol)